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Background: Neuroinflammation plays pivotal roles in the progression of cerebral ischemia injury. Prostaglandins
(PGs) as the major inflammatory mediators in the brain participate in the pathophysiological processes of cerebral
ischemia injury. Cyclooxygenase-2 (COX2) is the rate-limiting enzyme of PGs, and thus it is necessary to characterize
of the expression patterns of COX2 and its downstream products at the same time in a cerebral ischemia/reperfusion
(I/R) model.
Methods: The levels of prostacyclin (PGI2) and thromboxane (TXA2) and the expression of COX2 were detected in the
rat hippocampus at different time points after reperfusion (30 min, 2 h, 6 h, 24 h, 48 h, 7 d, and 15 d).
Results: The COX2 mRNA and protein expressions in hippocampus both remarkably increased at 30 min, and peaked
at 7 d after global cerebral I/R compared with the sham-operated group. The level of PGI2 significantly increased at 2 h
after reperfusion, with a peak at 48 h, but was still significantly higher than the sham-operated animals at 15 d. TXA2
level decreased at 30 min and 2 h after reperfusion, but significantly increased at 6 h and peaked at 48 h. PGI2/TXA2
ratio increased at 30 min after reperfusion, and peaked at 48 h compared with the sham-operated animals.
Conclusions: I/R injury significantly increased the COX2 expression, PGI2 and TXA2 levels, and the PGI2/TXA2 ratio in rat
hippocampus in a time-dependent manner. As a consequence, the increased PGI2 level and PGI2/TXA2 ratio may
represent a physiological mechanism to protect the brain against the neuronal damage produced by I/R injury.
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Cerebral ischemic injury with high morbidity, disability
and mortality worldwide has brought heavy psycho-
logical burden and economic pressures to patients and
the society [1]. It is therefore necessary to sufficiently
understand the pathophysiologic mechanisms and effect-
ive neuroprotective strategies involved in cerebral ische-
mia injury.
Cerebral ischemia is defined as a temporal or permanent
reduction in cerebral blood flow (CBF) that is insufficient
to meet the functional or metabolic demand by the central
nervous system (CNS). Reperfusion can restore CBF, but
can also exacerbate brain injury. Increasing evidence has* Correspondence: cqjqyang2004@aliyun.com
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unless otherwise stated.recently accumulated to support the notion that oxidative
stress and neuroinflammation play pivotal roles in the
progression of cerebral ischemia injury [2,3]. Inflamma-
tion is at least partially mediated by prostaglandins (PGs),
which are mediated by the rate-limiting enzyme cyclooxy-
genase (COX). A huge amount of free arachidonic acid
(AA) is released from membrane phospholipids after the
ischemic event, and then COX catalyzes the conversion of
AA into the intermediate PGH2, which is then metabolized
by cell-specific synthases to produce five PGs: prostacyclin
(PGI2), thromboxane A2 (TXA2), PGE2, PGF2α, and PGD2.
The five PGs bind to classes of G protein-coupled recep-
tors designated as IP, TP, EP (EP1, 2, 3, and 4), FP and DP
(DP1 and 2) to elicit their specific bio-effects on cyclic
adenosine monophosphate (cAMP), phosphatidylinositol
turnover, and intracellular calcium mobilization, respect-
ively [4]. Some PGs are pro-inflammatory mediators, butThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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COX: COX-1 and COX2. COX-1 is expressed constitu-
tively throughout the gastrointestinal system, kidneys, vas-
cular smooth muscle, and platelets, whereas COX2 is an
inducible form that contributes to fundamental brain func-
tions, such as synaptic activity, memory consolidation and
functional hyperemia under normal conditions in the
CNS [6], but its expression can be induced by a variety
of stimuli, including bacterial lipopolysaccharide (LPS),
pro-inflammatory cytokines, growth factors, and tumor
promoters [7]. COX2 participates in the neurodegener-
ative disease in a PGs-dependent manner [8]. Inhibition
of COX2 either pharmacologically or genetically de-
creases neuronal injury after cerebral ischemia [9,10].
However, long-term clinical trials show that chronic
blockade of COX in patients taking COX2 inhibitors
leads to an increased risk of cerebrovascular and car-
diovascular complications [11]. Therefore, it is necessary
to better understand the COX-modulated downstream
pathway. Efforts have been made to elucidate the neuro-
toxicity of COX2 with the hope of developing new thera-
peutic agents that avoid the detrimental side effects but
still retain the beneficial effects. A better strategy for treat-
ing cerebral ischemia injury may focus on modulating the
PGs, downstream of the COX pathway [12,13].
PGI2 and TXA2, which derive from PGH2 via the ac-
tion of prostacyclin and thromboxane A2 synthetase, re-
spectively, are important members of the PG family. The
balance between PGI2 and TXA2 plays a major role in
regulation of CBF in response to ischemia [14]. PGI2 an-
alogs and TXA2 antagonists are potentially useful for the
treatment in different ischemia animal models by im-
proving CBF [15,16]. More attention has been paid to
the roles of PGI2 and TXA2 in regulation of blood co-
agulation and vascular tone [17,18], but rarely to their
effects on neurons. In physiological conditions, PGI2 and
TXA2 are highly expressed in the rat cortex and hippo-
campus [19]. Focal cerebral ischemia reperfusion (I/R)
will lead to the expression of prostacyclin synthase in
the pyriform cortex, peri-infarct cortical area, subcor-
tical, and CA1 pyramidal neurons [20]. Takechi et al.
[21] found a novel subtype of IP receptor which is
expressed in neurons but not glial cells in the CNS and
is clearly distinct from the peripheral subtype in terms
of ligand specificity. TXA2 also participates in the pro-
gress of fibrillar Aβ-induced extrapyramidal motor dys-
function in rat striatum [22]. Their expression manner
and signaling pathways in the CNS are still unclear. The
roles of PGI2 and TXA2 in ischemic brain injury are not
yet fully elucidated.
Since PGI2 and TXA2 participate in the pathophysio-
logical processes of cerebral ischemia injury and COX2 is
their rate-limiting enzyme, it is necessary to characterize
of their expression patterns at the same time in a cerebralI/R model. The COX2 expression or the levels of PGs
have been extensively investigated in different cerebral is-
chemia animal models, such as the temporal and topo-
graphic profiles of COX2 expression during 24 h of focal
brain ischemia in rats [23], and the levels of TXA2 and
PGI2 in rat CA1 hippocampus within 4 h after global cere-
bral I/R with microdialysis probes [24]. However, their ob-
servation periods are relatively short, and since the effect
of cerebral ischemia on rat is long lasting, observation of
COX2 or its downstream alone cannot reflect their inter-
relation. To the best of our knowledge, the temporal ex-
pression profiles of COX2 and its downstream have not
been systematically reported at the same time in any is-
chemia model.
In this study, we will establish a global cerebral I/R rat
model to investigate the time course of COX2 expres-
sion, PGI2 and TXA2 levels, and the ratio of PGI2/TXA2
in the rat hippocampus at different time points after glo-
bal cerebral I/R. The results may provide important in-
sights into the mechanisms of ischemic brain injury and
provide therapeutic benefits in the future.
Experimental procedures
Animal groups
All experiments were performed following the Guide for
the Care and Use of Laboratory Animals and were ap-
proved by the Animal Care and Use Committee at
Chongqing Medical University. A total of 120 pathogen-
free male wistar rats with body weight of 200–250 g
were used. The animals were housed five per cage at
room temperature of 20 ± 2°C, 55 ± 10% humility, and
light on 12 h/d (08:00–20:00) with ad libitum access to
food and water. All animals were fasted for 12 h before
surgery and returned to the preoperative conditions
until sacrifice. The rats were randomly divided into 8
groups (n = 15 each): a sham-operated group, and 7
treated groups tested at 30 min, 2 h, 6 h, 24 h, 48 h, 7 d,
and 15 d after I/R respectively. From each group, 4 rats
were used for determination of cerebral edema, 3 rats
for histopathological examination, 4 rats for measure-
ment of SOD activity, MDA content, and PGI2 and
TXA2 levels, and 4 rats for detection of COX2 mRNA
and protein expressions in the hippocampus.
Establishment of global cerebral ischemia model
The bilateral common carotid arteries were occluded for
20 min combined with systemic hypotension and then
made in rats to establish a global cerebral I/R model
[25]. Briefly, the rats were anaesthetized with 4% chloral
hydrate (10 mL/kg, ip.) and in the dorsal position, the
neck area was shaved; both common carotid arteries and
the right common carotid vein were exposed carefully
by blunt dissection; after the right common carotid vein
was ligated at the distal end, a V-shaped incision was
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infusion (1 ml/100 g, 100 ml of saline containing 250 U
heparin) was injected into the vein, 30% of total blood
volume of a rat was extracted from the right common
carotid vein, and the bilateral common carotid arteries
were clamped with microaneurysm clips for 20 min.
Then the clips were removed, the extracted blood was
reinfused, and the incisions were sutured carefully. In
sham-operated animals, both common carotid arteries
were exposed but not occluded and blood was not with-
drawn from the carotid vein. The rectal temperature was
controlled carefully at 37 ± 0.5°C during the experiment
using a heating lamp and a heating pad.
Morris water maze test
Morris water maze was used to investigate the rats’
spatial learning and memory functions in the laboratory.
The maze was a round tank (150 cm in radius and
60 cm in height) filled with water at about 24°C. The
tank was divided into 4 equal quadrants (A - D). An in-
visible platform (25 cm in diameter) was submerged
2 cm below the water surface and placed at the midpoint
of one quadrant. The test was carried out according to a
previous protocol [26]. The rats were subjected to a
training phase (day 8 – 11 after I/R) and a testing phase
(day 12 after I/R). The animals were trained for 4 con-
secutive days at about the same time (8:00 – 11:00 pm)
with 4 trials each day. In each trial, the rats were left in
a new quadrant facing the wall and allowed to swim
freely to find the escape platform. If a rat failed within a
time limit of 180 s, it was guided to the platform by the
experimenter. If the rat succeeded, it was allowed to stay
on the platform for 10 s before the next animal was
tested. The test session was performed once on the test-
ing phase, the platform was removed from the tank, and
the rat was permitted to swim in the Morris water maze
until it located the platform. A video camera above the
water maze pool was linked to a computer, and recorded
the time of escape latency and the length of swimming
path.
Histopathologic examination
After deep anesthesia with 4% chloral hydrate (400 mg/
kg, ip), the rats were transcardially perfused with 200 ml
of cold saline, followed by 250 ml of phosphate buffer
solution (PBS, 0.1 M; pH 7.4) containing 4% paraformal-
dehyde. Then the brains were removed, and the middle
part of the brain was immersed in 4% paraformaldehyde
and kept at 4°C overnight, and the coronal brain was cut
to 5 μm thick sections. For each animal, 4 sections contain-
ing the dorsal hippocampus were mounted on paraffin-
coated slides and stained with hematoxylin-eosin to
examine the integrity of the CA1 pyramidal cell layers [27].
Hippocampus neuronal damage in the dorsal hippocampalCA1 subfield was detected at 400×. Pyramidal cells with a
distinct nucleus and nucleolus were regarded as intact,
while neurons showing typical signs of dark staining,
shrinkage and dysmorphic shape were considered as dam-
aged. The number of necrotic neuronal injured cells was
counted and expressed as percentage for each hippocampal
region.Measurement of SOD activity and MDA level
SOD activities and MDA content were assessed with
relevant detection kits (Nanjing Jiancheng Bioengineer-
ing Institute, China), using xanthine oxidase method and
thiobarbituric acid method respectively [28]. Briefly, 10%
hippocampus homogenate was prepared in ice-cold physio-
logical saline solution (0.9%), and after centrifugation at
4000 × g for 10 min, the supernatant was collected and
tested according to the manufacture’s directions.Measurement of 6-keto-PGF1α and TXB2 levels
Because both PGI2 and TXA2 have a very short half-life
and are ready to convert to 6-keto-PGF1α [29,30] and
TXB2 [31] respectively, we then measured 6-keto-PGF1α
and TXB2 levels. Briefly, hippocampus tissues were ho-
mogenized in a buffer containing 1 mM EDTA, 10 uM
indomethacin, and 0.1 M PBS. Homogenates were centri-
fuged at 12000 × g and 4°C for 15 min. Supernatants were
removed and assayed in triplicate using a 6-keto-PGF1a
and TXB2 enzyme linked immunosorbent assay (ELISA)
kit according to the manufacturer’s guidelines (Cayman
Chemical).Reverse transcriptase-polymerase chain reaction (RT-PCR)
The primers for COX2 and β-Actin were chosen from se-
quence in Genbank and synthesized by Sangon Biotech
Co., Ltd. (Shanghai, China). The COX2 primers were: for-
wards, 5′-CACGGACTTGCTCACTTTGT-3′; reverse,
5′-GAACGCTTTGCGGTACTCAT-3′, which result in a
162-bp PCR product. The β-Actin as an internal reference
primer was: forwards, 5′-AGAGGGAAATCGTGCGTG
AC-3′; reverse, 5′-GTGCTAGGAGCCAGGGCAGTA-3′,
which result in a 358.6 bp PCR product. PCR was per-
formed as follows: initial denaturation at 94 for 4 min;
35 cycles of 94°C for 15 s, 57.6 for 15 s, and 72 for 40 s;
then 72 for 5 min for the final extension. PCR products
were separated by electrophoresis using 2% agarose-0.5 ×
TAE gels containing 0.05 ug/ml ethidium bromide. The
band intensity was analyzed densitometrically using
Quantity One (Bio-Rad Laboratories, USA). Quantities of
PCR product were normalized by dividing the average
gray level of the β-actin amplication. In this experiment, 4
samples were all tested 3 times, and the average gray level
was taken.
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Equal amounts of samples (20 μg of protein) were sepa-
rated on 10% sodium dodecyl sulfate polyacrylamide gel
electropheresis (SDS-PAGE) and transferred to polyviny-
lidene difluoride membranes. The membranes were in-
cubated with 5% w/v dried fat-free milk in 0.05%
Tween-20 in Tris-buffered saline and Tween 20 (TBST)
at room temperature for 2 h. Then the membranes were
incubated with a primary rabbit anti-rat COX2 antibody
(1:100) at 4°C overnight. The second day the blots were
washed with TBST (10 min × 3) and exposed to the
secondary antibody (1:2000) at room temperature for
1 h. The membranes were washed again with TBST
(10 min × 3) and revealed with an enhanced chemilu-
minescence system (ECL kit; Pierce Biotechnology).
The expression in each sample was analyzed with
Quantity One (BioRad) and quantified with the ratio to
β-Actin. In each experiment, 4 samples were assayed
in triplicate, respectively, and the average value was
taken.
Immunohistochemistry
Immunohistochemistry was performed to investigate the
expression of COX2 in the rat hippocampus. Briefly,
hippocampus sections of 3 rats from each group were
dewaxed and rehydrated in decreasing concentrations
ethanol. Then the slides were blocked for endogenous
peroxidase in 3% H2O2 in methanol for 20 min at room
temperature. Slides were washed with PBS for several times
and pre-incubated in 1% BSA for 30 min at room
temperature. Thereafter, the slides were incubated with
anti-COX2 polyclonal rabbit (dilution 1:100) at 4°C over-
night. Then, the sections were incubated with biotinylated
secondary antibody (dilution 1:500) for 30 min at 37°C. Fi-
nally, the color was developed with 3, 30-diaminobenzidine
(DAB) reagent for 2 min. Images were observed using an
Olympus microscope system (Olympus, Tokyo, Japan).
Statistical analysis
The results of each group are expressed as mean ±
standard deviation (S.D.). Statistical analysis was ana-
lyzed with SPSS16.0 (IBM, USA). Differences between
groups were tested with one-way analysis of variance
(ANOVA). Further comparisons among groups were
made according to post-hoc test. P <0.05 was considered
as significant.
Results
Effects of global cerebral ischemia on CBF in rats
CBF was measured with a moorVMS-LDF laser Doppler
blood flow monitor during the operation phase. When the
common carotid arteries were clamped, CBF decreased
rapidly to 30% of the baseline within seconds. Upon therelease of carotid ligatures, CBF started to increase to 75%
of the pre-ischemic level within seconds (Figure 1A).
Morphological changes of rat hippocampus at different
time points after reperfusion
The sham-operated rats exhibited normal neurons with
well-structured, closely-arranged, clear and intact cellu-
lar form. Microscopic results showed obvious neuronal
injury following cerebral ischemia. Karyopyknosis and
swelling were observed in neurons from the ischemic rats
(Figure 1B). And the number of dead cells increased in
the hippocampal CA1 subfield in I/R rats (Figure 1C).
Effects of I/R on spatial learning and memory functions
in rats
At the training phase, the escape latency in all of the
groups tended to decrease over time. The escape latency
increased significantly in the I/R group compared to the
sham-operated group in the Morris water maze at both
the training phase and the test phase (Figure 1D).
Effects of global cerebral ischemia on superoxide
dismutase (SOD) activity and malondialdehyde (MDA)
content in hippocampus
The SOD activities and MDA content changed dynamic-
ally during the 15-d period. In the hippocampus, SOD
activities significantly decreased (P < 0.05) in the early
reperfusion periods (2, 6, 24, and 48 h) following global
cerebral ischemia, and minimized at 7 d (P < 0.01) com-
pared with the sham-operated group (Figure 1E1). By
contrast, the MDA content progressively increased from
30 min to 15 d after global cerebral ischemia and peaked
at 7 d (P < 0.01) (Figure 1E2).
Levels of 6-keto-PGF1α and TXB2 and the 6-keto-PGF1α/ TXB2
ratio in rat hippocampus at different time points
After global ischemia for 20 min, the 6-keto-PGF1α level
in rat hippocampus increased significantly at 2 h, with a
peak at 48 h, thereafter gradually decreased at 7 d and
15 d, but was still significantly higher than the sham-
operated animals (Figure 2A). The level of TXB2 signifi-
cantly decreased at 30 min and 2 h after global ischemia,
thereafter began to increase at 6 h (P >0.05) and peaked at
48 h compared to the sham-operated group (Figure 2B).
The 6-keto-PGF1α/TXB2 ratio in rat hippocampus in-
creased as early as 30 min after reperfusion, remained in-
creasing until 2 h, decreased at 6 h, but significantly
increased at 24 h and 48 h, and then decreased again at
7 d compared with the sham-operated animals (Figure 2C).
The effects of I/R on COX2 mRNA and protein (by WB)
expressions in rat hippocampus
Low levels of COX2 PCR products were observed in the
hippocampus of sham-operated rats. The COX2 mRNA
Figure 1 Change of cerebral blood flow, morphology, cell death rate, escape latency, SOD activities and MDA contents in I/R rat.
(A) Average cerebral blood flow measured before, during, and after global cerebral ischemia in rats. The level of CBF before ischemia was set to
100%. CBF decreased rapidly to 30% of the baseline during the ischemia phase and increased to 75% of the pre-ischemic level during the reperfusion
phase. (B) Effects of I/R on morphological change of rat hippocampal neurons. Representative microscopic photographs of hematoxylin-eosin–stained
rat hippocampal CA1 neurons at different reperfusion time points following 20 min of global ischemia. Sections are show at 400× power. (C) Group
data showing the cell death rate. Normal neurons in sham operated group is well structured, closely arranged, neurons in ischemia group showed
obviously karyopyknosis and swelling, the injury aggravated along with the reperfusion and peaked at 15 d. (D) The escape latency of rats in the sham
and operated groups. I/R rats had a significantly longer mean latency to find the platform compared with the sham group. (E) SOD activities (E1) and
MDA contents (E2) in the hippocampus at the different reperfusion time after 20 min of global ischemia in rats. SOD activity significantly decreased
after I/R injury, and reached maximal reduction at 7 d, MDA content progressively increased from 30 min to 15 d after and reached a peak level at 7 d.
(Compared with the sham group, *P < 0.05, **P < 0.01).
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Figure 2 Levels of 6-keto-PGF1α (A), TXB2 (B) and 6-keto-PGF1α/TXB2 ratio (C) in rat hippocampus at the different reperfusion time.
(Compared with the sham group, *P < 0.05, **P < 0.01).
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and peaked at 7 d, and thereafter decreased at 15 d, but
was still significantly higher compared with the sham-
operated group (Figure 3A). Then Western Blot was ap-
plied to determine whether upregulation of COX2 mRNA
resulted in increased synthesis of COX2 protein. As a re-
sult, the COX2 protein expression in the rat hippocampus
was similar to the COX2 mRNA expression. The COX2
protein expression peaked at 7 d after I/R and decreased
at 15 d (Figure 3B).
Expression of COX2 protein (by immunohistochemistry) in
rat hippocampus at different time points after reperfusion
The expression of COX2 was in the cytoplasm. In the
sham group, there was only a faint expression of COX2 in
CA1, but COX2 expression increased rapidly in hippo-
campus CA1 following global ischemia. There was noFigure 3 Time course change of COX2 mRNA (A) and protein (B) expr
increased at 30 min, and reached the peak at 7 d after I/R injury when com
group, *P < 0.05, **P < 0.01).significant increase of number of cells that express COX2,
but an increase of expression in the same population of
cells (Figure 4A). The COX2 in the CA1 significantly in-
creased at 30 min (P < 0.05) and peaked at 7 d (P < 0.01),
and thereafter decreased at 15 d, but was still significantly
higher compared with the sham-operated group (P < 0.01)
(Figure 4B).
Discussion
Oxidative stress has emerged as a key deleterious factor
in brain I/R [32]. Ischemic brain injury leads to the over-
production of free radicals [33], which damage cell
membranes as well as DNA and proteins by initiating
lipid peroxidation [34]. Brain in particular is highly sus-
ceptible to free radical-mediated insult, owing to its high
content of unsaturated fatty acids and low levels of pro-
tective antioxidants. SOD which is a specific scavengeression in I/R rat hippocampus. COX2 mRNA and protein remarkably
pared with that of sham operation group. (Compared with the sham
Figure 4 Time course change of COX2 protein expression in hippocampus of I/R rat. (A) Time course change of COX2 protein expression
in I/R rat hippocampus. (B) Group data showing the time course change of COX2 protein expression. Compared with that of sham operation group,
COX2 protein remarkably increased at 30 min after I/R, and reached the peak at 7 d after I/R. (Compared with the sham group, *P < 0.05, **P < 0.01).
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oxidant defenses by catalyzing the dismutation of super-
oxide anion into H2O2 and O2 [35]. MDA is one end
product and the biomarker of lipid peroxidation [36].
The SOD activities and MDA contents reflect the bal-
ance between oxidative and antioxidative levels in the
brain. Our experiments showed a sustained elevation of
MDA content and a steady decrease of SOD activity fol-
lowing I/R injury. Our findings are consistent with previ-
ous findings, such as that the increased level of lipid
peroxidation persists for several days following a brief
forebrain ischemia in the gerbil hippocampus [37].
These results together show that ischemic brain injury
will lead to the overproduction of free radicals if not
cleared timely, and will disturb the balance between oxi-
dative and antioxidative levels in the brain.
Accumulated evidence suggests that the enhanced
COX2 participates in the development of neuronal deathand in brain ischemia and neurodegenerative diseases
[38,39]. Zhao et al. [40] found that the number of COX2
immunostained cells increased at 12 h, peaked at 48 h,
and still elevated until 7 d after focal cerebral ischemia
in rats, and COX2 was localized mainly in neurons.
COX2 promoted the generation of free radicals when
catalyzing AA to PGs, which is associated with the neu-
rontoxicity of COX2 in cerebral ischemia [41]. Oxidative
stress can directly induce the transcription of neuronal
COX2 [42], which could lead to a vicious cycle associ-
ated with neurotoxicity. Our results demonstrated that
the time-dependent upregulation of COX2 mRNA and
the production of COX2 protein in rat hippocampus per-
sisted for 7 d after ischemia. It suggested that increase of
COX2 expression may involve in the brain injury.
The reasons lied in the increased risk of cerebrovascu-
lar and cardiovascular complications in patients after
long-term take of COX2 inhibitors are that COX2
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without the concomitant inhibition of TXA2, and could
promote hypertension and thrombosis, and increase car-
diovascular risks [43]. Our results demonstrated an up-
regulation of COX2 expression and an upregulation of
PGI2 and TXA2 levels at 20 min after global ischemia in
rat hippocampus. It is reported that increased COX2 ex-
pression is associated with increased PGI2 and TXA2
levels [44]. PGI2 level significantly increased in rat
hippocampus at 2 h with a peak at 48 h. Levels of TXA2
significantly decreased at 30 min and 2 h, thereafter
began to increase at 6 h and peaked at 48 h. Similarly,
Huttemeier et al. [24] found that the levels of PGI2 and
TXA2 in the extracellular fluid increased significantly
from 40 to 80 min and from 20 to 80 min after global
cerebral I/R, respectively. It is unclear why the level of
TXA2 decreased in the early period following I/R insult.
Interestingly, the peak time is 7 d for COX2 expression
and is 48 h for its downstream PGI2 and TXA2. The rea-
son is unclear and should be explored in the future.
Regarding their effects on cerebral I/R injury, the PGI2
and TXA2 bind to G protein-coupled receptors to exert
different bio-effects. The infarct volumes and neuro-
logical deficit scores were significantly greater in IP−/−
mice than in wildtype mice following focal cerebral is-
chemia [45]. Activation of IP receptor can attenuate ana-
tomical and functional damages following ischemic
stroke [45]. TXA2 receptor antagonist can ameliorate
brain edema and cerebral infarct areas following focal
cerebral ischemia [46], indicating that IP receptor is neu-
roprotective, while the TP receptor mediates harmful ef-
fects on cerebral ischemia injury.
The increased ratio of PGI2/TXA2 is valuable for
neuron-protection. It is reported that a favorable PGI2/
TXA2 ratio could protect the brain from injury [20,47].
PGI2/TXA2 ratio in rat hippocampus significantly in-
creased from 30 min to 7 d after I/R injury compared
with the sham-operated animals. The increased ratio
may represent a physiological mechanism to protect the
brain against the neuronal damage produced by I/R in-
jury. Similarly, the levels of PGI2 and TXA2 and the ratio
of PGI2/TXA2 were significantly higher in rat hippocam-
pal slices of 18- and 24-month-old animals compared to
3-month-old animals, probably contributing to protecting
the brain against aging-induced neuronal damage [48].
TP receptor antagonist and PGI2 alleviate brain injury
by regulating collateral blood flow through vascular
endothelium TP and IP receptors, respectively [46,49].
Xiao et al. [50] reported that the size of myocardial in-
farct in IP−/− mice was significantly larger than that in
wild-type mice after cardiac I/R injury, but there was no
such difference between TP−/− and wild-type mice, indi-
cating that the endogenous PGI2 attenuates I/R injury by
acting directly on the cardiac tissue, regardless of itsinhibitory effects on blood constituents. In the CNS,
prostacyclin synthase was induced in the pyriform cor-
tex, peri-infarct cortical area, subcortical, and CA1 pyr-
amidal neurons following focal cerebral ischemia, which
led to increased production of neuron PGI2 [20]. The
15R-TIC, a specific ligand for CNS-type PGI2 receptor,
protects hippocampal CA1 pyramidal neurons against
the ischemic delayed neuronal damage in gerbils [51].
The 15R-TIC also has a potent neuroprotective effect
against focal cerebral ischemia in a monkey middle cere-
bral artery occlusion (MCAO) model [52]. PGI2 has also
been proposed as an agonist of the endogenous PPARδ
(also known as PPARβ), and it can act through endogen-
ous PPARδ as a second signaling pathway that controls
cell fate [53]. However, Fauti et al. [54] argued that PGI2
is insufficient for PPARδ activation and is not a PPARδ
agonist in vivo. In the CNS, TXA2 receptor is expressed
at mRNA level in neurons, glia, and brain stem in nor-
mal rats [55]. Thromboxane A2 receptor mediates glial
morphological change due to activation of RhoA mainly
by G12/13 [56]. TXA2 can elicit stronger vagal or para-
sympathetic reflexes in rabbits when released during tis-
sue trauma depending on the location [57]. TP receptors
play a role in stimulation of afferent neurons and activation
of important cardiovascular and pulmonary vagal reflexes
[58]. Unilateral injection of Aβ-enhanced apomorphine-
induced circling ipsilaterally in rats and significantly el-
evated the level of TXA2, but TXA2 receptor antagonists
attenuated Aβ-enhanced circling behavior, and TXA2 me-
diated the fibrillar Aβ-induced impairment of striatal
motor function [22]. TXA2 also mediates iron-overload
cardiomyopathy by the TNF-α-associated calcineurin-
nuclear factor of activated T cells (NFAT) signaling
pathway [59]. The effects of TXA2 in the CNS are most
independent of its vascular tone, which has received much
more attention. PGI2 and TXA2 are involved in adjust-
ment of I/R injury by acting on the corresponding recep-
tors, but all those remain to be confirmed in the future.
Our study shows that although the level of PGI2 and ra-
tio of PGI2/TXA2 in the hippocampus were significantly
induced, the rats displayed obvious spatial learning and
memory dysfunctions and obvious hippocampus neurons
damage, probably because the increased PGI2 level and
PGI2/TXA2 ratio were insufficient to antagonize the I/R-
caused damage. Therefore, exogenous PGI2 agonists or
TXA2 antagonists should be supplied. The PGI2/TXA2
balance may play an important role in protecting the brain
from injury. All these need to be confirmed in the future.
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